Rapid identification of novel functional promoters for gene therapy

Journal of Molecular Medicine

Volumn 90, Issue 12, 2012, Pages 1487-1496

  Pringle, Ian A ^a,c   Gill, Deborah R ^a,c   Connolly, Mary M ^a,c   Lawton, Anna E ^a,c   Hewitt, Anne Marie ^a,c   Nunez Alonso, Graciela ^a,c   Cheng, Seng H ^b   Scheule, Ronald K ^b   Davies, Lee A ^a,c   Hyde, Stephen C ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GENZYME CORPORATION   (United States)

^c UK Cystic Fibrosis Gene Therapy Consortium   (United Kingdom)

Author keywords

CpG; Database; Gene therapy; Promoter; Transgene expression

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; LIPOSOME; MESSENGER RNA; PLASMID DNA;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; CPG ISLAND; ENHANCER REGION; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENE THERAPY; GENETIC DATABASE; IN VIVO GENE TRANSFER; LIVER; LUNG; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROMOTER REGION; TRANSCRIPTION REGULATION; TRANSGENE;

GENETIC THERAPY; GENETIC VECTORS; PROMOTER REGIONS, GENETIC; TRANSGENES;

EID: 84884213229     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0928-6     Document Type: Article

References (34)

1. Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J, Davies J, Smith SN, Browning J, Davies MG et al (1999) Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 353:947-954
2. Ruiz FE, Clancy JP, Perricone MA, Bebok Z, Hong JS, Cheng SH, Meeker DP, Young KR, Schoumacher RA, Weatherly MR et al (2001) A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum Gene Ther 12:751-761
3. Hyde SC, Pringle IA, Abdullah S, Lawton AE, Davies LA, Varathalingam A, Nunez-Alonso G, Green AM, Bazzani RP, Sumner-Jones SG et al (2008) CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat Biotechnol 26:549-551
4. Yew NS, Zhao H, Przybylska M, Wu IH, Tousignant JD, Scheule RK, Cheng SH (2002) CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther 5:731-738
5. Halees AS, Leyfer D, Weng Z (2003) PromoSer: a large-scale mammalian promoter and transcription start site identification service. Nucleic Acids Res 31:3554-3559
6. Halees AS, Weng Z (2004) PromoSer: improvements to the algorithm, visualization and accessibility. Nucleic Acids Res 32:W191-W194
7. Cavin Perier R, Junier T, Bucher P (1998) The eukaryotic promoter database EPD. Nucleic Acids Res 26:353-357
8. Schmid CD, Perier R, Praz V, Bucher P (2006) EPD in its twentieth year: towards complete promoter coverage of selected model organisms. Nucleic Acids Res 34:D82-D85
9. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC (2001) Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1 alpha promoter. Gene Ther 8:1539-1546
10. Pringle IA, Raman S, Sharp WW, Cheng SH, Hyde SC, Gill DR (2005) Detection of plasmid DNA vectors following gene transfer to the murine airways. Gene Ther 12:1206-1214
11. Davies LA, McLachlan G, Sumner-Jones SG, Ferguson D, Baker A, Tennant P, Gordon C, Vrettou C, Baker E, Zhu J et al (2008) Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol Ther 16:1283-1290
12. Liu F, Song Y, Liu D (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6:1258-1266
13. Song YK, Liu F, Zhang G, Liu D (2002) Hydrodynamics-based transfection: simple and efficient method for introducing and expressing transgenes in animals by intravenous injection of DNA. Methods Enzymol 346:92-105
14. Rose AC, Goddard CA, Colledge WH, Cheng SH, Gill DR, Hyde SC (2002) Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways. Gene Ther 9:1312-1320
15. Bazzani RP, Cai Y, Hebel HL, Hyde SC, Gill DR (2011) The significance of plasmid DNA preparations contaminated with bacterial genomic DNA on inflammatory responses following delivery of lipoplexes to the murine lung. Biomaterials 32:9854-9865
16. Davies LA, Hyde SC, Nunez-Alonso G, Bazzani RP, Harding-Smith R, Pringle IA, Lawton AE, Abdullah S, Roberts TC, McCormick D et al (2012) The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes. Biomaterials 33:5618-5627
17. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175-191
18. Saxonov S, Berg P, Brutlag DL (2006) A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci USA 103:1412-1417
19. Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J, Rouze P, Brunak S (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24:3439-3452
20. Brunak S, Engelbrecht J, Knudsen S (1991) Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 220:49-65
21. McLachlan G, Davidson H, Holder E, Davies LA, Pringle IA, Sumner-Jones SG, Baker A, Tennant P, Gordon C, Vrettou C et al (2011) Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Ther 18:996-1005
22. Riu E, Chen ZY, Xu H, He CY, Kay MA (2007) Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo. Mol Ther 15:1348-1355
23. Zabner J, Cheng SH, Meeker D, Launspach J, Balfour R, Perricone MA, Morris JE, Marshall J, Fasbender A, Smith AE et al (1997) Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J Clin Invest 100:1529-1537
24. Davies JC, Davies G, Gill DR, Hyde SC, Boyd AC, Innes JA, Porteous DJ, Cheng SH, Scheule RK, Higgins TH, Griesenbach U, Alton EW (2011) Safety and expression of a single dose of lipid-mediated CFTR gene therapy to the upper and lower airways of patients with CF. Pediatric Pulmonol 46(S34):281-281
25. Porteous DJ, Dorin JR, McLachlan G, Davidson-Smith H, Davidson H, Stevenson BJ, Carothers AD, Wallace WA, Moralee S, Hoenes C et al (1997) Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4:210-218
26. Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ, Kowalczyk TH, Hyatt SL, Fink TL, Gedeon CR et al (2004) Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 15:1255-1269
27. Gill DR, Southern KW, Mofford KA, Seddon T, Huang L, Sorgi F, Thomson A, MacVinish LJ, Ratcliff R, Bilton D et al (1997) A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4:199-209
28. Hyde SC, Southern KW, Gileadi U, Fitzjohn EM, Mofford KA, Waddell BE, Gooi HC, Goddard CA, Hannavy K, Smyth SE et al (2000) Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 7:1156-1165
29. Yew NS, Wysokenski DM, Wang KX, Ziegler RJ, Marshall J, McNeilly D, Cherry M, Osburn W, Cheng SH (1997) Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum Gene Ther 8:575-584
30. Kuramoto T, Nishikawa M, Thanaketpaisarn O, Okabe T, Yamashita F, Hashida M (2006) Use of lipoplex-induced nuclear factor-kappaB activation to enhance transgene expression by lipoplex in mouse lung. J Gene Med 8:53-62
31. Breuzard G, Tertil M, Goncalves C, Cheradame H, Geguan P, Pichon C, Midoux P (2008) Nuclear delivery of NFkappaB-assisted DNA/polymer complexes: plasmid DNA quantitation by confocal laser scanning microscopy and evidence of nuclear polyplexes by FRET imaging. Nucleic Acids Res 36:e71
32. Worthington J, Robson T, Scott S, Hirst D (2005) Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer. Gene Ther 12:1417-1423
33. Szymanski P, Anwer K, Sullivan SM (2006) Development and characterization of a synthetic promoter for selective expression in proliferating endothelial cells. J Gene Med 8:514-523
34. Santilli G, Almarza E, Brendel C, Choi U, Beilin C, Blundell MP, Haria S, Parsley KL, Kinnon C, Malech HL et al (2010) Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells. Mol Ther 19:122-132